Physician profile
Marie Hagman
NPI 1164800603
$1,972.76
in general payments reported to CMS, 2019-2025
11 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Critical Care Medicine (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $203).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $295 · 2022: $195 · 2023: $491 · 2024: $681 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,482.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $597.42 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Pascal |
| Boston Scientific Corporation | $361.56 | 2022-2024 | Watchman Access System, Vigilant X4 Crt-D, Watchman Flx |
| Medtronic, INC. | $303.70 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $189.38 | 2022-2025 | Triclip, Amplatzer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.49 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $119.35 | 2024-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $96.62 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $60.53 | 2024 | Arcalyst |
| Biosense Webster, INC. | $55.89 | 2024 | Carto 3 |
| Kestra Medical Technology Services, INC. | $40.91 | 2024 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $21.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Hagman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.